Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

NCT03573882 ·Status: TERMINATED ·Phase: PHASE3

rhTPO in Critical Patients With Thrombocytopenia

NCT02094248 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients

NCT00922883 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

NCT02407080 ·Status: COMPLETED ·Phase: PHASE1

The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment

NCT03673215 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA

NCT06254287 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of Eltrombopag in Platelet Refractory Thrombocytopenia

NCT01194167 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

NCT05382013 ·Status: UNKNOWN ·Phase: PHASE4

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit

NCT04767802 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

NCT01623167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia

NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

NCT02773290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

NCT04328727 ·Status: COMPLETED ·Phase: PHASE2

A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease

NCT05193201 ·Status: UNKNOWN ·Phase: PHASE1

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

NCT00571467 ·Status: TERMINATED ·Phase: PHASE1

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

NCT06673498 ·Status: RECRUITING ·Phase: PHASE2

Rituximab in Patients With Relapsed or Refractory TTP-HUS

NCT00531089 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04687072 ·Status: COMPLETED ·Phase: PHASE3

Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia

NCT01230775 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT05070845 ·Status: RECRUITING ·Phase: PHASE2

A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia

NCT02094417 ·Status: COMPLETED ·Phase: PHASE2

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

NCT00914927 ·Status: COMPLETED ·Phase: PHASE2

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

NCT04057040 ·Status: COMPLETED ·Phase: PHASE2

Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP

NCT07189910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4